Legislation To Produce And Research Cannabis Introduced

Generic 17 January 2019 | 0 Comments

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure.  The act ends the University of Mississippi’s existing monopoly on the growth of cannabis for […]

Tagged in , , ,

FDA Weighs In On Legal Status of Commercially Available ‘Hemp-Derived’ CBD Products

Generic 22 December 2018 | 0 Comments

Following yesterday’s passage of the 2018 Farm Bill, US Food and Drug Administration Commissioner Scott Gottleib issued a statement with regard to the agency’s oversight of products commercially marketed as ‘hemp-derived’ CBD. The FDA states: “We’re aware of the growing public interest in cannabis and cannabis-derived products, including cannabidiol (CBD). This increasing public interest in […]

Tagged in , , ,

NORML Submits 10,000+ Written Comments to the FDA for the Reconsideration of International Marijuana Prohibition

Generic 2 November 2018 | 0 Comments

On October 31, NORML hand delivered over 10,000 comments written by YOU, recommending that the World Health Organization (WHO) re-think their current prohibition of marijuana. Along with two of our fantastic interns, I drove to the US Food and Drug Administration (FDA) building in Rockville, Maryland. Earlier this month, The FDA put out a request […]

Tagged in ,

FDA Seeks Public Comments Regarding International Classification Of Cannabis

Generic 16 October 2018 | 0 Comments

The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration. The FDA says that the comments “will be considered in preparing a response […]

Tagged in , , ,

Congressional Committee Approves Legislation To Facilitate Clinical Cannabis Research

Generic 13 September 2018 | 0 Comments

Members of the House Judiciary Committee voted today in favor of legislation (HR 5634: The Medical Cannabis Research Act of 2018) to facilitate federally-approved clinical trials assessing the efficacy of whole-plant cannabis. The vote marks the first time that lawmakers have ever decided in favor of easing existing federal restrictions which limit investigators ability to […]

Tagged in , , ,